Stock listing
CIPLA Stock Price, News, Filings & Events — Cipla Ltd
Selected listing: CIPLA · NSE · INR · IN
This page tracks Cipla Ltd's CIPLA:NSE listing on NSE in INR for IN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CIPLA:NSE. CIPLA:NSE is the stock-level entry point for investors researching Cipla Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cipla Ltd is a public company listed on the Indian stock market under the ticker CIPLA. With a market capitalization of approximately ₹12.2 billion, Cipla is a prominent player in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of healthcare products. The company is known for its commitment to providing affordable medicines and improving access to healthcare.

- Ticker
- CIPLA:NSE
- Asset type
- Stock
- Market cap
- $11.86B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- NSE
- Currency
- INR
Cipla Ltd CIPLA:NSE stock context
This page tracks Cipla Ltd's CIPLA:NSE listing on NSE in INR for IN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CIPLA:NSE. CIPLA:NSE is the stock-level entry point for investors researching Cipla Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cipla Ltd is a public company listed on the Indian stock market under the ticker CIPLA. With a market capitalization of approximately ₹12.2 billion, Cipla is a prominent player in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of healthcare products. The company is known for its commitment to providing affordable medicines and improving access to healthcare.
Latest news from Cipla Ltd
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
September 4, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in...
September 3, 2026
Cipla Ltd Press Release Aug 31 2026
August 31, 2026
Cipla Ltd Press Release Jul 23 2026
July 23, 2026
Press Release May 13 2026
May 13, 2026
Research Cipla Ltd
Cipla Ltd investor report
Review AI stock analysis and investor report context for CIPLA:NSE.
Cipla Ltd company profile
View the public company page for Cipla Ltd on 6ix.
Cipla Ltd news
Read company news and market updates connected to Cipla Ltd.
Cipla Ltd investor events
Find investor webinars, events, and replay context for Cipla Ltd.